×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
A New Path Forward for Using Decentralized Clinical Trials
Session Chair(s)
Penny Randall, MD
Vice President and Head, CNS Center of Excellence
IQVIA, United States
Barriers are hindering the widespread use of decentralized clinical trials. However, new recommendations developed by CTTI offer new approaches to improve recruitment and retention, participant diversity, and the research experience for patients.
Learning Objective : Describe proven methods for executing decentralized clinical trials through telemedicine and mobile healthcare providers; Discuss actionable recommendations for navigating state medical licensing laws and issues with drug supply chain of custody; Identify the broad continuum of hybrid protocol designs possibilities for implementing decentralized clinical trials.
Speaker(s)
Panelist
Laura Byrnes Podolsky, JD, MPH
Science 37, United States
General Counsel
Panelist
Gail Adinamis
GlobalCare Clinical Trials, LLC, United States
CEO
Panelist
Michael O'Brien, CPA
MJO Consulting, LLC, United States
Life Sciences Consultant
Have an account?